文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

需体外膜氧合的重症患者气管切开时机与结局:单中心回顾性观察研究

Timing of tracheostomy and patient outcomes in critically ill patients requiring extracorporeal membrane oxygenation: a single-center retrospective observational study.
PubMed 文献 · J Intensive Care · 2022-12-30
一句话结论在接受ECMO并气管切开的成人重症患者中,气管切开时机越晚,住院死亡率越高(四分位每增一级校正OR 1.55,95%CI 1.03–2.35,趋势P=0.037)。

该单中心回顾性观察研究纳入2014年4月至2021年12月在一家三级中心ICU接受ECMO并气管切开的连续成人患者98例。按气管切开时机四分位分为≤15天、16–19天、20–26天、>26天四组,比较住院死亡率。结果显示第1四分位组住院死亡率最低(19.2%),第4四分位组最高(50.0%);多因素logistic回归显示气管切开时机四分位递增与住院死亡率显著相关(校正OR 1.55,95%CI 1.03–2.35,趋势P=0.037)。作者认为需进一步研究确定最佳气管切开时机。

要点

  • 98例ECMO并气管切开患者按时机四分位分组:≤15天、16–19天、20–26天、>26天,住院死亡率分别为19.2%(第1四分位)至50.0%(第4四分位)。
  • 多因素logistic回归显示气管切开时机四分位每增一级,住院死亡率校正OR 1.55(95%CI 1.03–2.35,趋势P=0.037)。
  • 气管切开并发症在各组间相当,但ECMO持续时间和ICU住院时间随气管切开时机四分位递增而显著增加。
  • 全部患者接受外科气管切开,其中35例在ECMO运行期间完成气管切开。
  • 作者认为需进一步研究以确定气管切开的最佳时机(就死亡率而言)。

适用人群与场景

  • 2014年4月至2021年12月在一家三级中心ICU连续收治、接受ECMO支持并接受气管切开的成人重症患者;293例接受ECMO治疗的患者中98例符合条件纳入分析。

诊断标准与关键阈值

  • 按气管切开时机四分位分组:第1四分位≤15天,第2四分位16–19天,第3四分位20–26天,第4四分位>26天。

处置流程与药物剂量

  • 全部98例患者接受外科气管切开;其中35例在ECMO运行期间接受气管切开。

研究设计与关键结果

  • 单中心回顾性观察研究,293例ECMO患者中98例纳入,按气管切开时机四分位分组比较。
  • 住院死亡率:第1四分位组19.2%最低,第4四分位组50.0%最高。
  • 多因素logistic回归:气管切开时机四分位递增与住院死亡率显著相关,校正OR 1.55(95%CI 1.03–2.35),趋势P=0.037。
  • 气管切开并发症在各组间相当;ECMO持续时间和ICU住院时间随气管切开时机四分位递增而显著增加。
  • 35例在ECMO运行期间接受气管切开。

证据类型、等级与局限

  • 证据类型:单中心回顾性观察研究。
  • 局限:原文未报告局限性;作者在结论中指出需进一步研究以确定就死亡率而言的最佳气管切开时机。

对床旁实践的改变

  • 作者认为需进一步研究以确定ECMO患者气管切开的最佳时机;原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is an integral method of life support in critically ill patients with severe cardiopulmonary failure; however, such patients generally require prolonged mechanical ventilation and exhibit high mortality rates. Tracheostomy is commonly performed in patients on mechanical ventilation, and its early implementation has potential advantages for favorable patient outcomes. This study aimed to investigate the association between tracheostomy timing and patient outcomes, including mortality, in patients requiring ECMO.

METHODS: We conducted a single-center retrospective observational study of consecutively admitted patients who were supported by ECMO and underwent tracheostomy during intensive care unit (ICU) admission at a tertiary care center from April 2014 until December 2021. The primary outcome was hospital mortality. Using the quartiles of tracheostomy timing, the patients were classified into four groups for comparison. The association between the quartiles of tracheostomy timing and mortality was explored using multivariable logistic regression models.

RESULTS: Of the 293 patients treated with ECMO, 98 eligible patients were divided into quartiles 1 (≤ 15 days), quartile 2:16-19 days, quartile 3:20-26 days, and 4 (> 26 days). All patients underwent surgical tracheostomy and 35 patients underwent tracheostomy during ECMO. The complications of tracheostomy were comparable between the groups, whereas the duration of ECMO and ICU length of stay increased significantly as the quartiles of tracheostomy timing increased. Patients in quartile 1 had the lowest hospital mortality rate (19.2%), whereas those in quartile 4 had the highest mortality rate (50.0%). Multivariate logistic regression analysis showed a significant association between the increment of the quartiles of tracheostomy timing and hospital mortality (adjusted odds ratio for quartile increment:1.55, 95% confidence interval 1.03-2.35, p for trend = 0.037).

CONCLUSIONS: The timing of tracheostomy in patients requiring ECMO was significantly associated with patient outcomes in a time-dependent manner. Further investigation is warranted to determine the optimal timing of tracheostomy in terms of mortality.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Nukiwa R, Uchiyama A, Tanaka A, et al. Timing of tracheostomy and patient outcomes in critically ill patients requiring extracorporeal membrane oxygenation: a single-center retrospective observational study. J Intensive Care. 2022. PMID: 36585705. doi:10.1186/s40560-022-00649-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。